Recursion Pharmaceuticals (RXRX) Total Debt (2020 - 2026)
Recursion Pharmaceuticals (RXRX) posted Total Debt of $16.4 million for Q1 2026, down 11.84% on a QoQ basis from $18.7 million in Q4 2025, and down 34.3% year-over-year from $25.0 million in Q1 2025.
Recursion Pharmaceuticals (RXRX) Total Debt (2020 - 2026) Analysis & Trends
Recursion Pharmaceuticals' Total Debt history runs 7 years deep, the most recent figure standing at $16.4 million for Q1 2026.
- Quarterly Total Debt fell 34.3% year-over-year to $16.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.4 million (down 34.3% YoY) and the FY2025 annual result came in at $18.7 million, down 32.03% from the prior year.
- Total Debt was $16.4 million for Q1 2026 at Recursion Pharmaceuticals, down from $18.7 million in the prior quarter.
- Across five years, Total Debt topped out at $31.0 million in Q2 2024 and bottomed at $536000.0 in Q4 2022.
- A 5-year average of $12.4 million and a median of $8.8 million in 2023 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt plunged 93.78% — and 2024, when it surged 2586.58%.
- Recursion Pharmaceuticals' Total Debt stood at $536000.0 in 2022, then surged by 113.06% to $1.1 million in 2023, then soared by 2303.42% to $27.4 million in 2024, then sank by 32.03% to $18.7 million in 2025, then dropped by 11.84% to $16.4 million in 2026.
- Business Quant data shows RXRX's Total Debt at $16.4 million in Q1 2026, $18.7 million in Q4 2025, and $20.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 959.06 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.57 Bn | 912.05 Mn | -6.02 Mn | 16.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.45 Mn |
| Dec 31, 2025 | 18.66 Mn |
| Sep 30, 2025 | 20.82 Mn |
| Jun 30, 2025 | 22.95 Mn |
| Mar 31, 2025 | 25.03 Mn |
| Dec 31, 2024 | 27.45 Mn |
| Sep 30, 2024 | 28.73 Mn |
| Jun 30, 2024 | 31.03 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 536,000.00 |
| Jun 30, 2022 | 586,000.00 |
| Mar 31, 2022 | 610,000.00 |
| Dec 31, 2021 | 633,000.00 |
| Sep 30, 2021 | 3.46 Mn |
| Jun 30, 2021 | 9.42 Mn |
| Mar 31, 2021 | 2.55 Mn |